TH
GSK icon

Timber Hill’s GSK GSK Stock Holding History

Timber Hill’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,440
Closed -$507K – 422
2017
Q4 		$507K Hold
11,440
– – 0.03% 384
2017
Q3 		$581K Buy
+11,440
New +$580K 0.05% 307
2017
Q2 		– Sell
-173,760
Closed -$9.16M – 1286
2017
Q1 		$9.16M Sell
173,760
-103,040
-37% -$5.23M 0.07% 207
2016
Q4 		$13.3M Buy
276,800
+206,080
+291% +$10.2M 0.06% 245
2016
Q3 		$3.81M Sell
70,720
-140,800
-67% -$7.72M 0.02% 564
2016
Q2 		$11.5M Buy
211,520
+155,280
+276% +$8.18M 0.05% 296
2016
Q1 		$2.85M Sell
56,240
-100,720
-64% -$5.02M 0.01% 757
2015
Q4 		$7.92M Buy
156,960
+75,120
+92% +$3.83M 0.04% 387
2015
Q3 		$3.93M Sell
81,840
-137,040
-63% -$7.13M 0.02% 663
2015
Q2 		$11.4M Buy
218,880
+184,560
+538% +$10.4M 0.05% 320
2015
Q1 		$1.98M Sell
34,320
-91,840
-73% -$5.27M 0.01% 1045
2014
Q4 		$6.74M Sell
126,160
-63,360
-33% -$3.54M 0.03% 457
2014
Q3 		$10.9M Buy
189,520
+10,080
+6% +$618K 0.05% 327
2014
Q2 		$12M Buy
179,440
+107,040
+148% +$7.25M 0.05% 291
2014
Q1 		$4.83M Sell
72,400
-12,160
-14% -$822K 0.02% 659
2013
Q4 		$5.64M Sell
84,560
-51,360
-38% -$3.33M 0.02% 705
2013
Q3 		$8.52M Sell
135,920
-127,280
-48% -$8.19M 0.03% 537
2013
Q2 		$16.4M Buy
+263,200
New +$16.7M 0.06% 271

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Timber Hill's GSK Position: Q4 2017 in Review

Timber Hill sold out of GSK (GSK) in Q4 2017, closing a stake of 22,265 shares — an estimated $1.03M sold.

Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters. The position peaked at $3.34M in Q3 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Timber Hill reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Timber Hill sold 22,265 GSK shares in Q4 2017, an estimated $1.03M.
  • Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters.
  • Timber Hill's GSK position peaked at $3.34M in Q3 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.